Blog
Research summaries about peptides with links to the original scientific publications.
Semaglutide: GLP-1 Receptor Evidence, Outcomes and Limitations
Semaglutide is a long-acting GLP-1 receptor agonist with extensive clinical evidence in regulated formulations. Research content must distinguish that evidence from catalogue…
Read more →
Thymosin Beta-4 and TB-500: Similar Names, Non-Identical Evidence
TB-500 is commonly discussed alongside thymosin beta-4, a naturally occurring 43-amino-acid actin-binding peptide. Evidence for full-length or recombinant thymosin beta-4 cannot automatically…
Read more →
Epitalon: Telomerase Hypotheses and the Limits of Anti-Ageing Claims
Epitalon is a tetrapeptide investigated in ageing-related laboratory models. Telomere biology is scientifically important, but telomere extension in cultured cells is not…
Read more →
Selank: GABAergic Hypotheses and Evidence Boundaries
Selank is a synthetic tuftsin-related heptapeptide associated with Russian anxiolytic research. Much of the clinical literature is geographically concentrated or difficult to…
Read more →
Retatrutide: Triple-Receptor Agonism and the Phase 2 Evidence
Retatrutide (LY3437943) is an investigational peptide engineered to activate GIP, GLP-1 and glucagon receptors. This combination is being studied as a way…
Read more →Information is provided for educational and research purposes only. It is not medical advice.